TIGIT and metastatic melanoma: Further, in studies assessing the function of CD8+ T cells in patients with stage IV advanced metastatic melanoma, TIGIT was found to be co-expressed with PD-1 on tumor-specific effector memory T cells, and TIGIT-expressing cells represented an activated T cell phenotype with high expression of HLA-DR and CD38 (54).